• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude Medical holds on to win in poaching spat with Biosense Webster

St. Jude Medical holds on to win in poaching spat with Biosense Webster

April 15, 2016 By Brad Perriello

GavelSt. Jude Medical (NYSE:STJ) hung on to a win over Johnson & Johnson (NYSE:JNJ) subsidiary Biosense Webster after a federal appeals court found that Biosense and the rep, Jose de Castro, breached the terms of his contract with St. Jude.

Originally a field technician for St. Jude, de Castro was promoted in 2009 to sales rep, signing a 3-year contract in 2011, according to court documents. Later that year, Biosense began courting de Castro, hoping his defection would also bring Sequoia Hospital’s business. Biosense offered to cover de Castro for any repercussions from breaking his deal with St. Jude; a day after he signed on with that company in February 2012, Biosense filed for declaratory judgment to invalidate the St. Jude contract, according to the documents.

But St. Jude won summary judgment from Judge Ann Montgomery of the U.S. District Court for Minnesota on all but the damages portion of the case; a jury later awarded St. Jude damages for the cost of replacing de Castro and for lost profits; including pre-judgment interest and legal fees, Biosense was on the hook for about $1.6 million, court records show.

Biosense and de Castro appealed to the U.S. Court of appeals for the 8th Circuit; a 3-judge panel on April 12 found unanimously for St. Jude.

“In sum, the district court correctly concluded that St. Jude’s term-of-years employment agreement with de Castro is valid and enforceable under Minnesota law and that Biosense was liable for tortuously interfering with that agreement,” the panel found.

It’s not the 1st time Biosense Webster and St. Jude have tangled in a poaching case. The accusations went the other way in a case in Florida involving 3 Biosense reps who allegedly jumped ship for St. Jude; in August 2014 a California federal judge tossed a suit filed against Biosense Webster by St. Jude and a former Biosense rep that sought to block that firm from enforcing a non-compete agreement.

Filed Under: Legal News, Wall Street Beat Tagged With: Biosense Webster, Johnson and Johnson, stjudemedical

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy